Quantum BioPharma Ltd. is trading at $3.85 (5.76% up) following a strong pre-market bid, though no company-specific catalyst has been identified in recent news.
- The upward move appears driven by broader early-session risk sentiment and sector rotation rather than a fresh corporate announcement.
- U.S. futures are trending higher, with the Nasdaq up 0.81%, providing a supportive environment for small-cap biotech names in pre-market trading.